TY - JOUR
T1 - Focused Transesophageal Echocardiography During Cardiac Arrest Resuscitation
T2 - JACC Review Topic of the Week
AU - Teran, Felipe
AU - Prats, Michael I.
AU - Nelson, Bret P.
AU - Kessler, Ross
AU - Blaivas, Michael
AU - Peberdy, Mary Ann
AU - Shillcutt, Sasha K.
AU - Arntfield, Robert T.
AU - Bahner, David
N1 - Funding Information:
Dr. Teran has received grant funding from the Zoll Foundation; is the owner of ResusMedX LLC; and over the last 3 years has received consulting honoraria payments from Fujifilm Sonosite for participation in educational events and expert panels related to point-of-care ultrasound including transesophageal echocardiography. Dr. Nelson is a member of Medical Advisory Boards for DiA Imaging Analysis Ltd. and EchoNous, Inc. Dr. Blaivas has received consulting honoraria payments from 410Medical, SonoSim, and Ethos Medical; and is the Chief Medical Officer for EchoNous, Inc. Dr. Shillcutt is the owner of Brave Enough LLC. Dr. Arntfield has received consulting honoraria payments from Philips Healthcare and Fujifilm Sonosite; and has served as a member of the Medical Advisory Boards for EchoNous, Inc. and Vave Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Robert J. Siegel, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper.
Funding Information:
Dr. Teran has received grant funding from the Zoll Foundation; is the owner of ResusMedX LLC; and over the last 3 years has received consulting honoraria payments from Fujifilm Sonosite for participation in educational events and expert panels related to point-of-care ultrasound including transesophageal echocardiography. Dr. Nelson is a member of Medical Advisory Boards for DiA Imaging Analysis Ltd. and EchoNous, Inc. Dr. Blaivas has received consulting honoraria payments from 410Medical, SonoSim, and Ethos Medical; and is the Chief Medical Officer for EchoNous, Inc. Dr. Shillcutt is the owner of Brave Enough LLC. Dr. Arntfield has received consulting honoraria payments from Philips Healthcare and Fujifilm Sonosite; and has served as a member of the Medical Advisory Boards for EchoNous, Inc. and Vave Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Robert J. Siegel, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper.
Publisher Copyright:
© 2020 American College of Cardiology Foundation
PY - 2020/8/11
Y1 - 2020/8/11
N2 - Focused transthoracic echocardiography (TTE) during cardiac arrest resuscitation can enable the characterization of myocardial activity, identify potentially treatable pathologies, assist with rhythm interpretation, and provide prognostic information. However, an important limitation of TTE is the difficulty obtaining interpretable images due to external and patient-related limiting factors. Over the last decade, focused transesophageal echocardiography (TEE) has been proposed as a tool that is ideally suited to image patients in extremis—those in cardiac arrest and periarrest states. In addition to the same diagnostic and prognostic role provided by TTE images, TEE provides unique advantages including the potential to optimize the quality of chest compressions, shorten cardiopulmonary resuscitation interruptions, guide resuscitative procedures, and provides a continuous image of myocardial activity. This review discusses the rationale, supporting evidence, opportunities, and challenges, and proposes a research agenda for the use of focused TEE in cardiac arrest with the goal to improve resuscitation outcomes.
AB - Focused transthoracic echocardiography (TTE) during cardiac arrest resuscitation can enable the characterization of myocardial activity, identify potentially treatable pathologies, assist with rhythm interpretation, and provide prognostic information. However, an important limitation of TTE is the difficulty obtaining interpretable images due to external and patient-related limiting factors. Over the last decade, focused transesophageal echocardiography (TEE) has been proposed as a tool that is ideally suited to image patients in extremis—those in cardiac arrest and periarrest states. In addition to the same diagnostic and prognostic role provided by TTE images, TEE provides unique advantages including the potential to optimize the quality of chest compressions, shorten cardiopulmonary resuscitation interruptions, guide resuscitative procedures, and provides a continuous image of myocardial activity. This review discusses the rationale, supporting evidence, opportunities, and challenges, and proposes a research agenda for the use of focused TEE in cardiac arrest with the goal to improve resuscitation outcomes.
KW - cardiac arrest
KW - focused cardiac ultrasound
KW - point-of-care ultrasound
KW - resuscitation
KW - transesophageal echocardiography
UR - http://www.scopus.com/inward/record.url?scp=85088632705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088632705&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2020.05.074
DO - 10.1016/j.jacc.2020.05.074
M3 - Review article
C2 - 32762909
AN - SCOPUS:85088632705
VL - 76
SP - 745
EP - 754
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 6
ER -